Not applicableStudy completedNCT02549222
What this trial is testing
A Open Label, Post Marketing Surveillance Study Following Transfusion of INTERCEPT Platelet Components
Who this might be right for
Transfusion Related Acute Lung Injury
Cerus Corporation 2,291